XDx Receives $12,500,000 New Financing
Jan 28, 2011 • Deals • TechZulu Inc.
| Company Name | XDx |
| Information Release Date | 1/28/2011 |
| Transaction Type | Debt |
| Amount | $12,500,000 |
| Round | Undisclosed |
| Proceeds Purpose | The financing provides the company with working capital to expand the commercialization of its FDA-cleared, innovative, non-invasive AlloMap® molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases, including lupus. |
